Skip to main content
Literatur
1.
Zurück zum Zitat Kim HS, Yoo TK, Park WC, Chae BJ (2020) The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-020-05550-4 [Epub ahead of print] Kim HS, Yoo TK, Park WC, Chae BJ (2020) The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society. Breast Cancer Res Treat. https://​doi.​org/​10.​1007/​s10549-020-05550-4 [Epub ahead of print]
Metadaten
Titel
HER2-positivity in mucinous cancer might be related to accompanying infiltrating ductal carcinoma histology
verfasst von
Kadri Altundag
Publikationsdatum
11.03.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05588-4

Weitere Artikel der Ausgabe 3/2020

Breast Cancer Research and Treatment 3/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.